Kavi Vyas

Kavi Vyas has extensive experience in the medical device industry, currently serving as Chief Commercial Officer at both Andromeda Surgical and Hatchleaf since 2024. Prior to these roles, Kavi Vyas held the position of Chief Commercial Officer at theator from August 2021 to February 2024 and served as Vice President of Marketing at Viz.ai from January 2019 to July 2021. Kavi Vyas's career at Penumbra, Inc. spanned from 2011 to January 2019, where responsibilities included Global Head of Embolization and the establishment of the global Vascular Embolization business. Earlier in the career, Kavi Vyas was a Marketing Manager at Medtronic Vascular and began the journey as a Marketing Specialist at CardioDx. Kavi Vyas earned a Bachelor of Arts degree in Human Biology from Stanford University from 2003 to 2007.